DeepMed Research

NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effect of Levetiracetam on Brain Excitability

Completed

Conditions: Healthy
Myoclonic Epilepsy

First Posted Date: 2002-12-10

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 14

Registration Number: NCT00006191

Locations: 🇺🇸
National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

PET Scans in Normal Volunteers and Patients With Fabry Disease

Completed

Conditions: Healthy
Fabry Disease

First Posted Date: 2002-12-10

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 24

Registration Number: NCT00005111

Locations: 🇺🇸
National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Bone Response to Enzyme Replacement in Gaucher's Disease

Phase 2

Completed

Conditions: Gaucher's Disease

First Posted Date: 2002-12-10

Last Posted Date: 2016-09-22

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 100

Registration Number: NCT00001416

Locations: 🇺🇸
National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients

Phase 2

Completed

Conditions: Multiple Sclerosis

First Posted Date: 2002-12-10

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 15

Registration Number: NCT00001669

Locations: 🇺🇸
National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors

Completed

Conditions: Retinal Diseases
Deafness
Kidney Diseases
Kidney Neoplasms
Neoplasms

First Posted Date: 2002-12-10

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 75

Registration Number: NCT00001668

Locations: 🇺🇸
National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System

Phase 2

Completed

Conditions: Neurodegenerative Disease
Parkinson's Disease

First Posted Date: 2002-12-10

Last Posted Date: 2006-07-13

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 42

Registration Number: NCT00001365

Locations: 🇺🇸
National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Study of LY300164 for the Treatment of Parkinson's Disease

Phase 2

Completed

Conditions: Dyskinesias
Parkinson Disease

First Posted Date: 2002-12-10

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 20

Registration Number: NCT00004576

Locations: 🇺🇸
National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Gentamicin Treatment of Muscular Dystrophy

Phase 1

Completed

Conditions: Becker Muscular Dystrophy
Duchenne Muscular Dystrophy

First Posted Date: 2002-12-10

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 4

Registration Number: NCT00005574

Locations: 🇺🇸
National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

Treatment of Huntington's Chorea With Amantadine

Phase 2

Completed

Conditions: Chorea
Huntington's Disease

First Posted Date: 2002-12-10

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 25

Registration Number: NCT00001930

Locations: 🇺🇸
National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

1-Octanol to Treat Essential Tremor

Phase 1

Completed

Conditions: Essential Tremor

First Posted Date: 2002-12-10

Last Posted Date: 2008-03-04

Lead Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Target Recruit Count: 12

Registration Number: NCT00001986

Locations: 🇺🇸
National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy